ライフサイエンスコーパス: implantation

1 each 4-month period (at 5 and 9 months after implantation).

2 term Intacs intracorneal ring segment (ICRS) implantation.

3 ointimal foam cell formation following stent implantation.

4 t from biventricular support early post-LVAD implantation.

5 % CI, 1.006-1.018]; p < 0.001) on the day of implantation.

6 21.0% for nonamyloid RCM, P=0.04) at device implantation.

7 not require marrow ablation or human tissue implantation.

8 or stability of biomaterial properties after implantation.

9 to treat these conditions without pacemaker implantation.

10 primary open versus closed strategy for port implantation.

11 25 patients, with a further 6 awaiting stent implantation.

12 ergone trabeculectomy and/or drainage device implantation.

13 ammatory markers three months after scaffold implantation.

14 revision surgery at 9.1 +/- 9.2 months after implantation.

15 etect and assess TRAS in the aspect of stent implantation.

16 atients lose this natural hearing soon after implantation.

17 ff CRT pacing following continuous flow LVAD implantation.

18 to physicians who performed an ICD or CRT-D implantation.

19 as prepared for culture on NetWells or mouse implantation.

20 = 0.027) at 12 months after iStent inject(R) implantation.

21 phagy and apoptosis before, during and after implantation.

22 after compared with the 1 year before sensor implantation.

23 ally tolerated GDMT, regardless of prior CRT implantation.

24 of the guiding wire necessary for safe stent implantation.

25 programme can be partially reset upon embryo implantation.

26 oteins after left ventricular assist devices implantation.

27 rength and significant radial dilation after implantation.

28 esponses were present two years after device implantation.

29 analysis if age <18 years at the time of GDD implantation.

30 abnormalities leading to permanent pacemaker implantation.

31 itigate these unintended side effects of IOL implantation.

32 g it with biocompatible material for chronic implantation.

33 was not associated with an increase in LVAD implantation.

34 ular tension ring and intraocular lens (IOL) implantation.

35 after left ventricular assist device (LVAD) implantation.

36 nt, without the expense and risk of a second implantation.

37 most common reason for electronic pacemaker implantation.

38 int was survival at 1 year after durable MCS implantation.

39 g factors, including RAB27B, at the onset of implantation.

40 of the transplant volume 24 h after surgical implantation.

41 Arm Test (ARAT) subtest 2 at 3 months after implantation.

42 was performed in 27 patients undergoing CRT implantation.

43 usion was maintained from organ retrieval to implantation.

44 ls for RVF in adult patients undergoing LVAD implantation.

45 ower at 1 year compared with the year before implantation (0.54 versus 1.25 events/patient-years, haz

46 pitalization was also lower following sensor implantation (1.67 versus 2.28 events/patient-years, haz

47 % required de novo pacemakers (median age at implantation 37 years; IQR: 29 to 48 years), 14% require

48 (1) technical, (2) menstruation, (3) embryo implantation, (4) pregnancy, (5) delivery, (6) graft rem

49 d donor kidney that had been biopsied before implantation according to a prespecified protocol in Fra

50 italization for heart failure, and pacemaker implantation after a TAVR procedure.

51 ta on consecutive patients who underwent MCS implantation after ECLS between January 2010 and August

52 an half of the patients undergoing pacemaker implantation after TAVR are pacemaker-dependent at midte

53 n; median age, 81 years) underwent pacemaker implantation after TAVR.

54 lso associated with lower rates of pacemaker implantation after the procedure (relative risk, 0.72; c

55 trabeculectomy and glaucoma drainage device implantation (Ahmed, Baerveldt, and Molteno valves), MIG

56 of implantation from the first to the second implantation allowing for examination of potential volum

57 unt the hypertensive phase compared with AGV implantation alone.

58 The mean +/- standard deviation time between implantation and ASN diagnosis was 10.5 +/- 1.3 years.

59 ads to an increase in bacterial burden post- implantation and develops pathology as a result.

60 on to hypoxia, which is essential for embryo implantation and establishment of pregnancy.

61 he most dreaded complications related to SCS implantation and may prevent patients from receiving ade

62 Decidual immune cells facilitate embryo implantation and placenta development.

63 therefore, necessary in order to ensure safe implantation and positioning of the catheter in those ca

64 ure, and lipids, assessed at 12 months after implantation, and again, at 12 months after the removal

65 was performed according to age, sex, year of implantation, and prosthesis type and position.

66 used was pediatric cataract surgery with IOL implantation, and the primary outcome measure was the pr

67 stent implantation, two flow diverter stent implantations, and hybrid neurosurgery.

68 going risk of MACE beyond 1 year after stent implantation are necessary.

69 ) mice are infertile due to defective embryo implantation arising from a lack of LIF, a critical impl

70 have biologically relevant effects following implantation as they enter the recipient's circulation.

71 uppression of tumor growth upon intracranial implantation, as well as significantly reduced microvess

72 o bioprosthesis, was new permanent pacemaker implantation at 30 days.

73 Twenty-three patients underwent cell implantation at eight UK hospitals a median of 7 months

74 round population; the composite of pacemaker implantation, atrioventricular block, and sinoatrial dys

75 4-30.2; p = 0.001), and recent subdural grid implantation (beta = 42.8, 95%CI 11.8-73.8; p = 0.009).

76 relatively older designs (high incidence of implantation between 1988 and the early 1990s).

77 uated patients undergoing PA pressure sensor implantation between September 1, 2014, and October 11,

78 Our study used computed tomography (CT) and implantation biopsy to investigate donated kidney featur

79 after left ventricular assist device (LVAD) implantation but subsequently declines.

80 outcomes were not inferior to those of ACIOL implantation, but the severity of preoperative pathologi

81 ct area percentage, defect depth percentage, implantation cell number, body weight, tissue source, an

82 m into epithelial-like cells surrounding the implantation chamber forming an avascular zone called th

83 During implantation, cytotrophoblasts undergo epithelial-to-mes

84 a are severely sub-fertile due to defects in implantation, decidualization, and endometrial receptivi

85 ormulas are infertile due in part to uterine implantation defects.

86 anisms by which neonatal GEN exposure causes implantation defects.

87 red randomized trial, early prophylactic ICD implantation demonstrated lower total and cardiac mortal

88 ference between membranous septum length and implantation depth (DeltaMSID) >=3 mm (odds ratio, 7.58

89 y cusp, but not membranous septum length nor implantation depth alone, are predictive of long-term pa

90 racteristics were collected, including valve implantation depth and membranous septum length, an anat

91 fect overlying the Intacs body, the intended implantation depth measured by high-magnification slit l

92 rapy (censoring eyes receiving an implant on implantation) developed glaucoma (hazard ratio [HR] = 5.

93 of cell specification in early mammalian pre-implantation development are based mainly on mouse studi

94 genetic information during germ cell and pre-implantation development by ensuring that the methylatio

95 present the first detailed analysis of post-implantation development of aneuploid human embryos.

96 Here, we determine the extent of post-implantation development of human embryos bearing common

97 hPSC correspond to an earlier stage of post-implantation development than mouse epiblast stem cells.

98 tiple stages of primordial germ cell and pre-implantation development, we find that the methylation s

99 Preventive VT ablation before ICD implantation did not reduce mortality or hospitalization

100 iStent Inject TBS implantation during cataract surgery seems to be cost ef

101 that underwent trabeculectomy or tube-shunt implantation during the study period.

102 The value of CT for catheter-delivered valve implantation (eg, transcatheter aortic and mitral valve

103 e a powerful platform for investigating post-implantation embryogenesis in a dish.

104 Expression profiling in human pre-implantation embryos and oocytes reveals that unlike in

105 in humans to regulate X-linked genes in pre-implantation embryos and PGCs.

106 Human pre-implantation embryos are an exception, in which dosage c

107 cessibility, and the biomechanically dynamic implantation environment are significant impediments to

108 ly, we profile the transcriptome of the post-implantation epiblast and all PGC stages in rat to revea

109 (EpiSCs), as further established in the peri-implantation epiblast in vivo.

110 ation arising from a lack of LIF, a critical implantation factor of uterine gland origin.

111 ial glands, features of posteriorization and implantation failure.

112 IA adenocarcinoma and prior bilateral breast implantation for cosmesis.

113 or heart failure, cardiogenic shock, or LVAD implantation from 2012 to 2015.

114 tudy, we used the variation in the timing of implantation from the first to the second implantation a

115 iological testing, and pre-emptive pacemaker implantation have been described.

116 t occur during organ retrieval, storage, and implantation have been relatively neglected since the de

117 hazard for death in the first 6 months after implantation (hazard ratio, 2.18 [1.79-2.66]; P<0.001).

118 coma anterior segment surgery at the time of implantation (HR, 13; P = 0.0085).

119 ical chemical conditions, several early post-implantation human embryo developmental landmarks, inclu

120 Early post-implantation human embryonic development has been challe

121 We further show that starvation in pre-implantation ICM-derived mouse ESCs induces a reversible

122 lantation and left ventricular assist device implantation if advanced therapies are indicated and not

123 elated to an anatomic failure at the site of implantation in an advanced disease.

124 sidual natural acuity did not decrease after implantation in any patient.

125 easibility of both Sapien 3 and Evolut R/PRO implantation in bicuspid aortic valve anatomy; a higher

126 ted with increased ventricular assist device implantation in blacks.

127 Although GDD implantation in children is relatively safe and effectiv

128 isual axis opacification is common after IOL implantation in early childhood.

129 implantable cardioverter defibrillator (ICD) implantation in early selected high-risk patients after

130 gs applied can be effectively reduced by XEN implantation in eyes suffering from NTG, PEX and seconda

131 acoemulsification and intraocular lens (IOL) implantation in eyes with uveitis.

132 y (VAO) after primary intraocular lens (IOL) implantation in infancy are necessary.

133 ses from 96 epilepsy patients with electrode implantation in left or right primary, secondary, and/or

134 ntly, co-cultures studied in vitro, and upon implantation in mice, revealed similar tumor growth dyna

135 ted at < 7 months of age despite primary IOL implantation in most children in the group aged 7 to 24

136 Hydrogel implantation in mouse and porcine models of hindlimb isc

137 with contemporary drug-eluting stents, stent implantation in NIRS-defined LRPs was not associated wit

138 after implantable cardioverter-defibrillator implantation in patients with nonischemic cardiomyopathy

139 the IOP lowering-effect of iStent inject(R) implantation in patients with OAG.

140 Glaucoma drainage device (GDD) implantation in the anterior chamber are associated with

141 polymer with tunable degradation rates, for implantation in the brain.

142 key features of mammalian development after implantation, including germ-layer specification and axi

143 h, reintervention, cardiac electronic device implantation, infection, thromboembolic event, hemodialy

144 iming of extracorporeal membrane oxygenation implantation influences the renal prognosis of these pat

145 After 5 years of implantation, INTACS-treated eyes could present with an

146 Following implantation into a rat aortic model, hiPSC-derived TEVG

147 ored at 4 degrees C for 43-48 hours prior to implantation into ABO-compatible, nonsensitized, MHC-mis

148 ancreatic islets seeded in a bioscaffold for implantation into diabetic recipients.

149 o to promote blood vessel outgrowth prior to implantation into immunocompromised mice.

150 of human neural stem cells by intracerebral implantation is feasible in a multicentre study.

151 Implantation is initiated when an embryo attaches to the

152 rforming circular craniotomies for coverslip implantation, large craniotomies for implanting transpar

153 s associated with younger age at the time of implantation (<1 year; HR, 27; P = 0.0053) and concurren

154 llator and cardiac resynchronization therapy implantation, LVEF improvement (>35%) and recovery (>=50

155 Human neural stem cell implantation may offer improved recovery from stroke.

156 At the implantation microenvironment, macrophages usually fuse

157 +) from intramedullary pins in a rat femoral implantation model, delivering a maximum potential conce

158 ucose is required for the development of pre-implantation mouse embryos, but the mechanism accounting

159 tivation and limited tumor growth in a tumor implantation mouse model.

160 With implantation, mouse stromal cells begin to transform int

161 t who underwent PKE combined with either XEN implantation (n = 47) or NPDS (n = 58) between May 2013

162 on [n=55], or left ventricular assist device implantation [n=9]).

163 mes and patient satisfaction after bilateral implantation of a bifocal diffractive intraocular lens w

164 ered from the site of injury by the surgical implantation of a bioscaffold, the inflammatory response

165 Here, we demonstrate the approach to implantation of a cardiac graft into the intra-abdominal

166 o the right and left atria, respectively, by implantation of a covered stent in the SVC.

167 e lens extraction by phacoemulsification and implantation of a CT ASPHINA 409 IOL.

168 The implantation of a double piezoelectric layer inside the

169 compare the efficacy and safety of 12-month implantation of a duodeno-jejunal bypass liner (DJBL) wi

170 Previously, feasibility of transvenous implantation of a lead at the left ventricular (LV) endo

171 of the anastomoses, de-airing of the graft, implantation of a long-term telemetry device for invasiv

172 Three valve-in-ring patients required the implantation of a second valve, which led to an overall

173 20/200) of each subject underwent subretinal implantation of a single 3.5x6.25 mm CPCB-RPE1 implant w

174 perature has traditionally required surgical implantation of a telemeter, but this invasive procedure

175 Eyes that underwent implantation of AGV experienced a lower incidence of hyp

176 Implantation of an Acrysof, Tecnis, or Envista IOL rando

177 tly available therapy for chronic SND is the implantation of an electronic pacemaker.

178 Implantation of an implantable cardioverter-defibrillato

179 tial higher risk of bowel perforation during implantation of an indwelling peritoneal catheter.

180 Surgical implantation of CPCB-RPE1 targeted to the area of GA in

181 These data support the implantation of dMCS in carefully selected ECMO patients

182 Implantation of drug-eluting stents (DES) is the dominan

183 results provide clear evidence that chronic implantation of EEG electrodes is associated with signif

184 nts having age-related cataract surgery with implantation of either a plate-haptic, c-loop haptic, or

185 lent issue in studies that involve prolonged implantation of electrochemical probes in the brain.

186 ciliary neurotrophic factor (CNTF), and the implantation of eMSCs into the lateral ventricle activat

187 Early implantation of extracorporeal membrane oxygenation may

188 SIGNIFICANCE STATEMENT This study shows that implantation of extradural electrodes provokes meningeal

189 efractive lens exchange (RLE) followed by an implantation of FineVision IOL (PhysIOL).

190 mild or moderate OAG health states received implantation of iStent Inject during cataract surgery ve

191 Implantation of multiple modules can cover extended brai

192 Implantation of NPM-ALK-transformed CD4+ T lymphocytes i

193 r, a major drawback is the need for invasive implantation of optical fibers.

194 Mice that were tumor-free 100 days after implantation of orthotopic tumors were rechallenged with

195 Intraperitoneal implantation of pancreatic islets seeded within the copo

196 Unlike implantation of splenic morsels in the great omentum, ou

197 with a GFP-expressing vector and subsequent implantation of syngeneic tumor cells showed >80% GFP ma

198 Five patients with implantation of the Argus II Retinal Prosthesis were enr

199 It is demonstrated that implantation of the biomaterial patch following injury e

200 ant form that occurs as a result of surgical implantation of the donor organ.

201 The total time for construction and implantation of the in vivo compressive cranial window i

202 out back-calculation of the toric axis after implantation of the IOL.

203 ere measured in recipient diabetic mice upon implantation of the islet-seeded biomaterial coupled wit

204 The implantation of the monofocal CT ASPHINA 409 IOL was ben

205 Subcutaneous implantation of the porous materials did not cause inten

206 Implantation of the PRIMA did not decrease the residual

207 ts underwent cataract surgery with bilateral implantation of the TFNT00 (n = 129) or SN60AT (n = 114)

208 and fatal diabetes, we found that peripheral implantation of these spheres in mice led to remarkable

209 zed the effects of chronic cranial electrode implantation on glymphatic fluid transport and in provok

210 We discovered that the human window of implantation opens with an abrupt and discontinuous tran

211 ature suggests that BADM grafts represent an implantation option for lower eyelid retraction repair.

212 er method can be further processed (e.g., by implantation or annealing) to achieve a particular outco

213 alter germline DNA methylation imprints pre-implantation or later in gestation.

214 subcortical structures, we observed whether implantation or stimulation affected structural volume.

215 ome of all-cause mortality, LV assist device implantation, or heart transplantation was assessed.

216 using a set of 97 euploid embryos capable of implantation outperformed 15 trained embryologists (75.2

217 Angio-CT followed by stent-graft implantation over a short time interval (within the same

218 thalmitis after trabeculectomy or tube-shunt implantation (P = 0.761, log-rank test).

219 nt paravalvular leak (P=0.004), second valve implantation (P=0.013), and valve embolization (P=0.009)

220 d in subluminal stromal cells at the time of implantation, plays a crucial role during early pregnanc

221 hermore, a CNN trained to assess an embryo's implantation potential directly using a set of 97 euploi

222 for the determination of transfer order and implantation potential using time-lapse data collected t

223 Percutaneous pulmonary valve implantation (PPVI) has become an important treatment of

224 earts as well as R and nonresponders at LVAD implantation (pre-LVAD) and transplantation (post-LVAD).

225 on of a custom-made marmoset chair, head-cap implantation, preparation of the sharp electrode and gui

226 medical devices as rigidity facilitates the implantation process, while flexibility and softness fav

227 in HRQOL following ventricular assist device implantation, provided the conditions are not a contrain

228 Taken together, we propose that implantation quality depends on appropriate angiogenic e

229 Remodeling After Transcatheter Aortic Valve Implantation [RASTAVI]; NCT03201185).

230 Although a significant increase in implantation rate was observed among blacks from early-a

231 mediate changes in ventricular assist device implantation rates by race.

232 However, the early and nonadopter changes in implantation rates were not statistically different from

233 r from which the physician who performed the implantation received the largest payment.

234 otocol and a splenectomy at the time of rBEL implantation reduced the immune responses and resulted i

235 arterial extracorporeal membrane oxygenation implantation regressed within 12 hours after extracorpor

236 Embryo implantation relies on precise hormonal regulation, asso

237 Multiple-site implantation reveals hypoxia and neighboring vessels as

238 itinol thin films spatially conformed to the implantation site, fostered the rapid expansion of T cel

239 blast and syncytiotrophoblast within ectopic implantation sites from women with EP.

240 The implantation sites restore to their normal architecture

241 injections were given intraperitoneally and implantation sites visualized.

242 post-processed to create 3D patient-specific implantation sites.

243 rrespond to pluripotent cells at a late post-implantation stage of embryogenesis.

244 dian=82 days) left ventricular assist device implantation (stage D; primary analysis) and ARNI therap

245 ssion is robustly up-regulated at early post-implantation stages in the primary decidual zone (PDZ) s

246 ertake compensatory proliferation during the implantation stages to confer embryonic viability.

247 metrial epithelium in species with different implantation strategies that may contribute to pregnancy

248 The implantation strategy for totally implantable venous acc

249 n management encompassing patient selection, implantation strategy, and preoperative and perioperativ

250 of morphing electronics to self-heal during implantation surgery allows a reconfigurable and seamles

251 erative periods, phacoemulsification and IOL implantation surgery can be safe and effective in eyes w

252 olic events after transcatheter aortic-valve implantation (TAVI) in patients who do not have an indic

253 Transcatheter aortic valve implantation (TAVI) still presents complications: parava

254 ts had successful transcatheter aortic valve implantation (TAVI).

255 Our approach builds on a bilateral tumor implantation technique in a murine metastatic breast can

256 iewed shows no superiority of any single IOL implantation technique in the absence of zonular support

257 m complication profiles of these various IOL implantation techniques.

258 the physician who performed an ICD or CRT-D implantation than each other manufacturer individually.

259 rgest payment to the physician who performed implantation than they were from each other individual m

260 n +/-0.5 diopter (D); in eyes with toric IOL implantation that met certain inclusion criteria, 80%, 8

261 Around implantation, the epiblast (Epi) transits from naive to

262 Upon implantation, the epiblast and extraembryonic ectoderm o

263 During the year after sensor implantation, the mean rate of daily pressure transmissi

264 Following implantation, the naive pluripotent epiblast of the mous

265 However, with single implantation, the physical properties of these devices l

266 Transcatheter mitral valve implantation (TMVI) is emerging as an alternative to sur

267 ime to event end point was the time from ICD implantation to first appropriate ICD therapy.

268 reventive VT ablation (undertaken before ICD implantation to prevent ICD shocks for VT) and deferred

269 T trial (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therap

270 Remodeling After Transcatheter Aortic Valve Implantation) trial is an ongoing randomized clinical tr

271 n Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry retrospectively included

272 methods including coiling with regular stent implantation, two flow diverter stent implantations, and

273 my combined with anterior vitrectomy +/- IOL implantation (US-Cat: 98.65%; BS-Cat: 95.24%; BT-Cat: 10

274 paroscopic total hepatectomy and liver graft implantation using a preexisting midline incision.

275 nts who underwent transcatheter aortic valve implantation using new-generation Evolut R/PRO or Sapien

276 background population; the composite of ICD implantation, ventricular arrhythmias, and cardiac arres

277 Post-implantation visual outcomes in patients with the Argus

278 ith higher rates of mortality, defibrillator implantation, VT ablation (adjusted HR: 4.68; 95% CI: 2.

279 (11.4) years, and the follow-up period after implantation was 3.2 (3.8) years.

280 The mean (SD) age at DBS implantation was 41.0 (11.4) years, and the follow-up pe

281 Successful device implantation was 98% (100 of 102).

282 vitro to simulate graft calcifications upon implantation was characterized nondestructively using fl

283 rgest payment to the physician who performed implantation was determined.

284 Cardiac inflammation before implantation was negatively associated with response to

285 Initial intraocular lens implantation was not commonly performed in all groups (U

286 Concurrent phacoemulsification with lens implantation was performed in 52 cases (52%).

287 fe-threatening arrhythmias necessitating ICD implantation, we compared outcomes of preventive VT abla

288 arterial extracorporeal membrane oxygenation implantation were excluded.

289 patients with glaucoma who required GDD tube implantation were included.

290 pitalization for heart failure and pacemaker implantation were more frequently reported in the VIV TA

291 The osteotomies and spring implantation were performed to simulate the skull expans

292 ological disease scheduled for elective port implantation were randomized to a primary open or closed

293 al study, a large proportion of ICD or CRT-D implantations were performed by physicians who received

294 eculectomy or glaucoma drainage device (GDD) implantation who later underwent DMEK (study group) were

295 cs in secretory phase endometrium during the implantation window and in first-trimester uterine decid

296 ome transcriptionally upregulated during the implantation window.

297 shell to eliminate iron overload, and BMSCs implantation with high-molecular-weight keratin hydrogel

298 The effects of device implantation with regards to biocompatibility and brain

299 underwent endomyocardial biopsies before CRT implantation, with histological quantification of fibros

300 solates with insufficient beta-cell mass for implantation within 72 hours can be cultured for 96 hour